<DOC>
	<DOCNO>NCT00047658</DOCNO>
	<brief_summary>Study GIPF-002 phase 2 study design characterize biologic clinical effect IFN-g 1b . The objective Study characterize biologic clinical effect IFN-g 1b administered patient idiopathic pulmonary fibrosis ( IPF ) . The Study conduct multiple site enroll 30 patient IPF fail treatment corticosteroid .</brief_summary>
	<brief_title>A Study Safety Clinical Effects Interferon Gamma-1b Patients With Idiopathic Pulmonary Fibrosis ( IPF )</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-gamma</mesh_term>
	<criteria>Male Female 2079 year old</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>November 2007</verification_date>
</DOC>